Barbara M. Bryant - Concepedia

Author

Barbara M. Bryant

Constellation Pharmaceuticals (United States)ORCID

Also Known As

B. BRYANT, B. Bryant, BERTHA E. BRYANT, Barb Bryant, Barbara Bryant, Barbara M Bryant, Barbara M. Bryant, Barbara M. Bryant, E Wong

Publications

5.7K

Citations

H-Index

Concepts

All Affiliations

Constellation Pharmaceuticals (United States)Millennium Engineering and Integration (United States)Mayo Clinic in Arizona University of Pennsylvania Harvard University

About

Barbara M. Bryant is an author at Constellation Pharmaceuticals (United States) specializing in medicine, cell biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	15	3.6K
2	Natural Sciences	3	3	283
3	Health Sciences	2	2	175
4	Engineering	1	1	23
5	Public Health	1	1	15

Barbara M. Bryant

Publications

5.5K

Citations

H-Index

Page 1

	Year	Citations
Targeting MYC dependence in cancer by inhibiting BET bromodomains Jennifer A. Mertz, Andrew R. Conery, Barbara M. Bryant, Proceedings of the National Academy of Sciences Myc TranscriptChromatinTranscriptional RegulationSystems BiologyMyc Dependence	2011	1.1K
Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma Jonathan J. Keats, Rafaël Fonseca, Marta Chesi, Cancer Cell Hematological MalignancyMedicineCancer Cell BiologyMultiple MyelomaCancer Genetics	2007	980
Characterizing gene sets with FuncAssociate Gabriel F. Berriz, Oliver D. King, Barbara M. Bryant, Bioinformatics	2003	467
Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib George Mulligan, Constantine S. Mitsiades, Barbara M. Bryant, Blood	2006	409
Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen Michael P. Menden, Dennis Wang, Mike J. Mason, Nature Communications	2019	350
Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families Melanie M. Mahtani, Elisabeth Widén, Markku Lehto, Nature Genetics Genetic DeterminantGeneticsDiabetesGenetic EpidemiologyType 2	1996	327
Molecular Dissection of Hyperdiploid Multiple Myeloma by Gene Expression Profiling Wee Joo Chng, Shaji Kumar, Scott VanWier, Cancer Research	2007	257
BET bromodomain inhibition suppresses TH17-mediated pathology Deanna A. Mele, Andrés Salmerón, Srimoyee Ghosh, The Journal of Experimental Medicine InflammationCytokineAutoimmune DiseaseAllergyBet Inhibitor	2013	236
An Alternative Approach to ChIP-Seq Normalization Enables Detection of Genome-Wide Changes in Histone H3 Lysine 27 Trimethylation upon EZH2 Inhibition Brian Egan, Chih-Chi Yuan, Madeleine Craske, PLoS ONE Histone ModificationsEpigenetic ChangeGeneticsMolecular BiologyEpigenetics	2016	157
Thiazolidinedione Treatment Decreases Bone Mineral Density in Type 2 Diabetic Men Subhashini Yaturu, Barbara M. Bryant, Sushil K. Jain Diabetes Care Fracture DiagnosticsFoot FracturesOrthopaedic SurgeryOsteoporosisBone Disease	2007	156

Page 1